Viewing Study NCT06098651


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2025-12-25 @ 9:37 PM
Study NCT ID: NCT06098651
Status: COMPLETED
Last Update Posted: 2025-09-29
First Post: 2023-09-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of DCR-STAT3 in Adults With Solid Tumors
Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module